Precision Medicine-Global Market Status & Trend Report 2016-2026 Top 20 Countries Data
Report Summary
Precision Medicine-Global Market Status & Trend Report 2016-2026 Top 20 Countries Data offers a comprehensive analysis on Precision Medicine industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Precision Medicine 2016-2021, and development forecast 2022-2026
Main manufacturers/suppliers of Precision Medicine worldwide and market share by regions, with company and product introduction, position in the Precision Medicine market
Market status and development trend of Precision Medicine by types and applications
Cost and profit status of Precision Medicine, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Precision Medicine market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Precision Medicine industry.
The report segments the global Precision Medicine market as:
Global Precision Medicine Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Precision Medicine Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
Diagnostics
Therapies
Global Precision Medicine Market: Application Segment Analysis (Consumption Volume and Market Share 206-2026; Downstream Customers and Market Analysis)
Oncology
Neurosciences
Immunology
Respiratory
Others
Global Precision Medicine Market: Manufacturers Segment Analysis (Company and Product introduction, Precision Medicine Sales Volume, Revenue, Price and Gross Margin):
Johnson & Johnson
Roche
Labcorp
Abbott Laboratories
Novartis
Illumina
GE Healthcare
Intel Corporation
Biomrieux Sa
Cepheid
IBM
Qiagen
Thermo Fisher Scientific
Randox Laboratories
Almac Group
Healthcore
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Precision Medicine-Global Market Status & Trend Report 2016-2026 Top 20 Countries Data offers a comprehensive analysis on Precision Medicine industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Precision Medicine 2016-2021, and development forecast 2022-2026
Main manufacturers/suppliers of Precision Medicine worldwide and market share by regions, with company and product introduction, position in the Precision Medicine market
Market status and development trend of Precision Medicine by types and applications
Cost and profit status of Precision Medicine, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Precision Medicine market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Precision Medicine industry.
The report segments the global Precision Medicine market as:
Global Precision Medicine Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Precision Medicine Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
Diagnostics
Therapies
Global Precision Medicine Market: Application Segment Analysis (Consumption Volume and Market Share 206-2026; Downstream Customers and Market Analysis)
Oncology
Neurosciences
Immunology
Respiratory
Others
Global Precision Medicine Market: Manufacturers Segment Analysis (Company and Product introduction, Precision Medicine Sales Volume, Revenue, Price and Gross Margin):
Johnson & Johnson
Roche
Labcorp
Abbott Laboratories
Novartis
Illumina
GE Healthcare
Intel Corporation
Biomrieux Sa
Cepheid
IBM
Qiagen
Thermo Fisher Scientific
Randox Laboratories
Almac Group
Healthcore
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF PRECISION MEDICINE
1.1 Definition of Precision Medicine in This Report
1.2 Commercial Types of Precision Medicine
1.2.1 Diagnostics
1.2.2 Therapies
1.3 Downstream Application of Precision Medicine
1.3.1 Oncology
1.3.2 Neurosciences
1.3.3 Immunology
1.3.4 Respiratory
1.3.5 Others
1.4 Development History of Precision Medicine
1.5 Market Status and Trend of Precision Medicine 2016-2026
1.5.1 Global Precision Medicine Market Status and Trend 2016-2026
1.5.2 Regional Precision Medicine Market Status and Trend 2016-2026
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Precision Medicine 2016-2021
2.2 Sales Market of Precision Medicine by Regions
2.2.1 Sales Volume of Precision Medicine by Regions
2.2.2 Sales Value of Precision Medicine by Regions
2.3 Production Market of Precision Medicine by Regions
2.4 Global Market Forecast of Precision Medicine 2022-2026
2.4.1 Global Market Forecast of Precision Medicine 2022-2026
2.4.2 Market Forecast of Precision Medicine by Regions 2022-2026
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Precision Medicine by Types
3.2 Sales Value of Precision Medicine by Types
3.3 Market Forecast of Precision Medicine by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Precision Medicine by Downstream Industry
4.2 Global Market Forecast of Precision Medicine by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Precision Medicine Market Status by Countries
5.1.1 North America Precision Medicine Sales by Countries (2016-2021)
5.1.2 North America Precision Medicine Revenue by Countries (2016-2021)
5.1.3 United States Precision Medicine Market Status (2016-2021)
5.1.4 Canada Precision Medicine Market Status (2016-2021)
5.1.5 Mexico Precision Medicine Market Status (2016-2021)
5.2 North America Precision Medicine Market Status by Manufacturers
5.3 North America Precision Medicine Market Status by Type (2016-2021)
5.3.1 North America Precision Medicine Sales by Type (2016-2021)
5.3.2 North America Precision Medicine Revenue by Type (2016-2021)
5.4 North America Precision Medicine Market Status by Downstream Industry (2016-2021)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Precision Medicine Market Status by Countries
6.1.1 Europe Precision Medicine Sales by Countries (2016-2021)
6.1.2 Europe Precision Medicine Revenue by Countries (2016-2021)
6.1.3 Germany Precision Medicine Market Status (2016-2021)
6.1.4 UK Precision Medicine Market Status (2016-2021)
6.1.5 France Precision Medicine Market Status (2016-2021)
6.1.6 Italy Precision Medicine Market Status (2016-2021)
6.1.7 Russia Precision Medicine Market Status (2016-2021)
6.1.8 Spain Precision Medicine Market Status (2016-2021)
6.1.9 Benelux Precision Medicine Market Status (2016-2021)
6.2 Europe Precision Medicine Market Status by Manufacturers
6.3 Europe Precision Medicine Market Status by Type (2016-2021)
6.3.1 Europe Precision Medicine Sales by Type (2016-2021)
6.3.2 Europe Precision Medicine Revenue by Type (2016-2021)
6.4 Europe Precision Medicine Market Status by Downstream Industry (2016-2021)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Precision Medicine Market Status by Countries
7.1.1 Asia Pacific Precision Medicine Sales by Countries (2016-2021)
7.1.2 Asia Pacific Precision Medicine Revenue by Countries (2016-2021)
7.1.3 China Precision Medicine Market Status (2016-2021)
7.1.4 Japan Precision Medicine Market Status (2016-2021)
7.1.5 India Precision Medicine Market Status (2016-2021)
7.1.6 Southeast Asia Precision Medicine Market Status (2016-2021)
7.1.7 Australia Precision Medicine Market Status (2016-2021)
7.2 Asia Pacific Precision Medicine Market Status by Manufacturers
7.3 Asia Pacific Precision Medicine Market Status by Type (2016-2021)
7.3.1 Asia Pacific Precision Medicine Sales by Type (2016-2021)
7.3.2 Asia Pacific Precision Medicine Revenue by Type (2016-2021)
7.4 Asia Pacific Precision Medicine Market Status by Downstream Industry (2016-2021)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Precision Medicine Market Status by Countries
8.1.1 Latin America Precision Medicine Sales by Countries (2016-2021)
8.1.2 Latin America Precision Medicine Revenue by Countries (2016-2021)
8.1.3 Brazil Precision Medicine Market Status (2016-2021)
8.1.4 Argentina Precision Medicine Market Status (2016-2021)
8.1.5 Colombia Precision Medicine Market Status (2016-2021)
8.2 Latin America Precision Medicine Market Status by Manufacturers
8.3 Latin America Precision Medicine Market Status by Type (2016-2021)
8.3.1 Latin America Precision Medicine Sales by Type (2016-2021)
8.3.2 Latin America Precision Medicine Revenue by Type (2016-2021)
8.4 Latin America Precision Medicine Market Status by Downstream Industry (2016-2021)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Precision Medicine Market Status by Countries
9.1.1 Middle East and Africa Precision Medicine Sales by Countries (2016-2021)
9.1.2 Middle East and Africa Precision Medicine Revenue by Countries (2016-2021)
9.1.3 Middle East Precision Medicine Market Status (2016-2021)
9.1.4 Africa Precision Medicine Market Status (2016-2021)
9.2 Middle East and Africa Precision Medicine Market Status by Manufacturers
9.3 Middle East and Africa Precision Medicine Market Status by Type (2016-2021)
9.3.1 Middle East and Africa Precision Medicine Sales by Type (2016-2021)
9.3.2 Middle East and Africa Precision Medicine Revenue by Type (2016-2021)
9.4 Middle East and Africa Precision Medicine Market Status by Downstream Industry (2016-2021)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF PRECISION MEDICINE
10.1 Global Economy Situation and Trend Overview
10.2 Precision Medicine Downstream Industry Situation and Trend Overview
CHAPTER 11 PRECISION MEDICINE MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Precision Medicine by Major Manufacturers
11.2 Production Value of Precision Medicine by Major Manufacturers
11.3 Basic Information of Precision Medicine by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Precision Medicine Major Manufacturer
11.3.2 Employees and Revenue Level of Precision Medicine Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 PRECISION MEDICINE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Johnson & Johnson
12.1.1 Company profile
12.1.2 Representative Precision Medicine Product
12.1.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Johnson & Johnson
12.2 Roche
12.2.1 Company profile
12.2.2 Representative Precision Medicine Product
12.2.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Roche
12.3 Labcorp
12.3.1 Company profile
12.3.2 Representative Precision Medicine Product
12.3.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Labcorp
12.4 Abbott Laboratories
12.4.1 Company profile
12.4.2 Representative Precision Medicine Product
12.4.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Abbott Laboratories
12.5 Novartis
12.5.1 Company profile
12.5.2 Representative Precision Medicine Product
12.5.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Novartis
12.6 Illumina
12.6.1 Company profile
12.6.2 Representative Precision Medicine Product
12.6.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Illumina
12.7 GE Healthcare
12.7.1 Company profile
12.7.2 Representative Precision Medicine Product
12.7.3 Precision Medicine Sales, Revenue, Price and Gross Margin of GE Healthcare
12.8 Intel Corporation
12.8.1 Company profile
12.8.2 Representative Precision Medicine Product
12.8.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Intel Corporation
12.9 Biomrieux Sa
12.9.1 Company profile
12.9.2 Representative Precision Medicine Product
12.9.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Biomrieux Sa
12.10 Cepheid
12.10.1 Company profile
12.10.2 Representative Precision Medicine Product
12.10.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Cepheid
12.11 IBM
12.11.1 Company profile
12.11.2 Representative Precision Medicine Product
12.11.3 Precision Medicine Sales, Revenue, Price and Gross Margin of IBM
12.12 Qiagen
12.12.1 Company profile
12.12.2 Representative Precision Medicine Product
12.12.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Qiagen
12.13 Thermo Fisher Scientific
12.13.1 Company profile
12.13.2 Representative Precision Medicine Product
12.13.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific
12.14 Randox Laboratories
12.14.1 Company profile
12.14.2 Representative Precision Medicine Product
12.14.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Randox Laboratories
12.15 Almac Group
12.15.1 Company profile
12.15.2 Representative Precision Medicine Product
12.15.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Almac Group
12.16 Healthcore
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PRECISION MEDICINE
13.1 Industry Chain of Precision Medicine
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF PRECISION MEDICINE
14.1 Cost Structure Analysis of Precision Medicine
14.2 Raw Materials Cost Analysis of Precision Medicine
14.3 Labor Cost Analysis of Precision Medicine
14.4 Manufacturing Expenses Analysis of Precision Medicine
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Precision Medicine in This Report
1.2 Commercial Types of Precision Medicine
1.2.1 Diagnostics
1.2.2 Therapies
1.3 Downstream Application of Precision Medicine
1.3.1 Oncology
1.3.2 Neurosciences
1.3.3 Immunology
1.3.4 Respiratory
1.3.5 Others
1.4 Development History of Precision Medicine
1.5 Market Status and Trend of Precision Medicine 2016-2026
1.5.1 Global Precision Medicine Market Status and Trend 2016-2026
1.5.2 Regional Precision Medicine Market Status and Trend 2016-2026
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Precision Medicine 2016-2021
2.2 Sales Market of Precision Medicine by Regions
2.2.1 Sales Volume of Precision Medicine by Regions
2.2.2 Sales Value of Precision Medicine by Regions
2.3 Production Market of Precision Medicine by Regions
2.4 Global Market Forecast of Precision Medicine 2022-2026
2.4.1 Global Market Forecast of Precision Medicine 2022-2026
2.4.2 Market Forecast of Precision Medicine by Regions 2022-2026
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Precision Medicine by Types
3.2 Sales Value of Precision Medicine by Types
3.3 Market Forecast of Precision Medicine by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Precision Medicine by Downstream Industry
4.2 Global Market Forecast of Precision Medicine by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Precision Medicine Market Status by Countries
5.1.1 North America Precision Medicine Sales by Countries (2016-2021)
5.1.2 North America Precision Medicine Revenue by Countries (2016-2021)
5.1.3 United States Precision Medicine Market Status (2016-2021)
5.1.4 Canada Precision Medicine Market Status (2016-2021)
5.1.5 Mexico Precision Medicine Market Status (2016-2021)
5.2 North America Precision Medicine Market Status by Manufacturers
5.3 North America Precision Medicine Market Status by Type (2016-2021)
5.3.1 North America Precision Medicine Sales by Type (2016-2021)
5.3.2 North America Precision Medicine Revenue by Type (2016-2021)
5.4 North America Precision Medicine Market Status by Downstream Industry (2016-2021)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Precision Medicine Market Status by Countries
6.1.1 Europe Precision Medicine Sales by Countries (2016-2021)
6.1.2 Europe Precision Medicine Revenue by Countries (2016-2021)
6.1.3 Germany Precision Medicine Market Status (2016-2021)
6.1.4 UK Precision Medicine Market Status (2016-2021)
6.1.5 France Precision Medicine Market Status (2016-2021)
6.1.6 Italy Precision Medicine Market Status (2016-2021)
6.1.7 Russia Precision Medicine Market Status (2016-2021)
6.1.8 Spain Precision Medicine Market Status (2016-2021)
6.1.9 Benelux Precision Medicine Market Status (2016-2021)
6.2 Europe Precision Medicine Market Status by Manufacturers
6.3 Europe Precision Medicine Market Status by Type (2016-2021)
6.3.1 Europe Precision Medicine Sales by Type (2016-2021)
6.3.2 Europe Precision Medicine Revenue by Type (2016-2021)
6.4 Europe Precision Medicine Market Status by Downstream Industry (2016-2021)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Precision Medicine Market Status by Countries
7.1.1 Asia Pacific Precision Medicine Sales by Countries (2016-2021)
7.1.2 Asia Pacific Precision Medicine Revenue by Countries (2016-2021)
7.1.3 China Precision Medicine Market Status (2016-2021)
7.1.4 Japan Precision Medicine Market Status (2016-2021)
7.1.5 India Precision Medicine Market Status (2016-2021)
7.1.6 Southeast Asia Precision Medicine Market Status (2016-2021)
7.1.7 Australia Precision Medicine Market Status (2016-2021)
7.2 Asia Pacific Precision Medicine Market Status by Manufacturers
7.3 Asia Pacific Precision Medicine Market Status by Type (2016-2021)
7.3.1 Asia Pacific Precision Medicine Sales by Type (2016-2021)
7.3.2 Asia Pacific Precision Medicine Revenue by Type (2016-2021)
7.4 Asia Pacific Precision Medicine Market Status by Downstream Industry (2016-2021)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Precision Medicine Market Status by Countries
8.1.1 Latin America Precision Medicine Sales by Countries (2016-2021)
8.1.2 Latin America Precision Medicine Revenue by Countries (2016-2021)
8.1.3 Brazil Precision Medicine Market Status (2016-2021)
8.1.4 Argentina Precision Medicine Market Status (2016-2021)
8.1.5 Colombia Precision Medicine Market Status (2016-2021)
8.2 Latin America Precision Medicine Market Status by Manufacturers
8.3 Latin America Precision Medicine Market Status by Type (2016-2021)
8.3.1 Latin America Precision Medicine Sales by Type (2016-2021)
8.3.2 Latin America Precision Medicine Revenue by Type (2016-2021)
8.4 Latin America Precision Medicine Market Status by Downstream Industry (2016-2021)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Precision Medicine Market Status by Countries
9.1.1 Middle East and Africa Precision Medicine Sales by Countries (2016-2021)
9.1.2 Middle East and Africa Precision Medicine Revenue by Countries (2016-2021)
9.1.3 Middle East Precision Medicine Market Status (2016-2021)
9.1.4 Africa Precision Medicine Market Status (2016-2021)
9.2 Middle East and Africa Precision Medicine Market Status by Manufacturers
9.3 Middle East and Africa Precision Medicine Market Status by Type (2016-2021)
9.3.1 Middle East and Africa Precision Medicine Sales by Type (2016-2021)
9.3.2 Middle East and Africa Precision Medicine Revenue by Type (2016-2021)
9.4 Middle East and Africa Precision Medicine Market Status by Downstream Industry (2016-2021)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF PRECISION MEDICINE
10.1 Global Economy Situation and Trend Overview
10.2 Precision Medicine Downstream Industry Situation and Trend Overview
CHAPTER 11 PRECISION MEDICINE MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Precision Medicine by Major Manufacturers
11.2 Production Value of Precision Medicine by Major Manufacturers
11.3 Basic Information of Precision Medicine by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Precision Medicine Major Manufacturer
11.3.2 Employees and Revenue Level of Precision Medicine Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 PRECISION MEDICINE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Johnson & Johnson
12.1.1 Company profile
12.1.2 Representative Precision Medicine Product
12.1.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Johnson & Johnson
12.2 Roche
12.2.1 Company profile
12.2.2 Representative Precision Medicine Product
12.2.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Roche
12.3 Labcorp
12.3.1 Company profile
12.3.2 Representative Precision Medicine Product
12.3.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Labcorp
12.4 Abbott Laboratories
12.4.1 Company profile
12.4.2 Representative Precision Medicine Product
12.4.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Abbott Laboratories
12.5 Novartis
12.5.1 Company profile
12.5.2 Representative Precision Medicine Product
12.5.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Novartis
12.6 Illumina
12.6.1 Company profile
12.6.2 Representative Precision Medicine Product
12.6.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Illumina
12.7 GE Healthcare
12.7.1 Company profile
12.7.2 Representative Precision Medicine Product
12.7.3 Precision Medicine Sales, Revenue, Price and Gross Margin of GE Healthcare
12.8 Intel Corporation
12.8.1 Company profile
12.8.2 Representative Precision Medicine Product
12.8.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Intel Corporation
12.9 Biomrieux Sa
12.9.1 Company profile
12.9.2 Representative Precision Medicine Product
12.9.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Biomrieux Sa
12.10 Cepheid
12.10.1 Company profile
12.10.2 Representative Precision Medicine Product
12.10.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Cepheid
12.11 IBM
12.11.1 Company profile
12.11.2 Representative Precision Medicine Product
12.11.3 Precision Medicine Sales, Revenue, Price and Gross Margin of IBM
12.12 Qiagen
12.12.1 Company profile
12.12.2 Representative Precision Medicine Product
12.12.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Qiagen
12.13 Thermo Fisher Scientific
12.13.1 Company profile
12.13.2 Representative Precision Medicine Product
12.13.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific
12.14 Randox Laboratories
12.14.1 Company profile
12.14.2 Representative Precision Medicine Product
12.14.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Randox Laboratories
12.15 Almac Group
12.15.1 Company profile
12.15.2 Representative Precision Medicine Product
12.15.3 Precision Medicine Sales, Revenue, Price and Gross Margin of Almac Group
12.16 Healthcore
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PRECISION MEDICINE
13.1 Industry Chain of Precision Medicine
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF PRECISION MEDICINE
14.1 Cost Structure Analysis of Precision Medicine
14.2 Raw Materials Cost Analysis of Precision Medicine
14.3 Labor Cost Analysis of Precision Medicine
14.4 Manufacturing Expenses Analysis of Precision Medicine
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
